Original Research

Published on 05 May 2023

Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals

in Vaccines and Molecular Therapeutics

Joana Barros-Martins
Swantje I. Hammerschmidt
Gema Morillas Ramos
Anne Cossmann
Laura Hetzel
Ivan Odak
Miriam Köhler
Metodi V. Stankov
Christiane Ritter
Michaela Friedrichsen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1166589

3,058 views
7 citations

Original Research

Published on 05 May 2023

A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts

in Vaccines and Molecular Therapeutics

Peter Lorenz
Felix Steinbeck
Franz Mai
Emil C. Reisinger
Brigitte Müller-Hilke

Frontiers in Immunology

doi 10.3389/fimmu.2023.1192395

2,463 views
2 citations

Original Research

Published on 03 May 2023

Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer

in Vaccines and Molecular Therapeutics

Yanan Tong
Guoxiu Lu
Zhiguo Wang
Shanhu Hao
Guoxu Zhang
Hongwu Sun

Frontiers in Immunology

doi 10.3389/fimmu.2023.1154818

2,141 views
3 citations

Original Research

Published on 02 May 2023

A self-binding immune complex vaccine elicits strong neutralizing responses against herpes simplex virus in mice

in Vaccines and Molecular Therapeutics

Andrew G. Diamos
Mary D. Pardhe
Melissa H. Bergeman
Aigerim S. Kamzina
Michelle P. DiPalma
Sara Aman
Artemio Chaves
Kenneth Lowe
Jacquelyn Kilbourne
Ian B. Hogue

Frontiers in Immunology

doi 10.3389/fimmu.2023.1085911

2,704 views
1 citation

Original Research

Published on 01 May 2023

Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice

in Vaccines and Molecular Therapeutics

Fernando Silveira
Mariana Rivera-Patron
Nikita Deshpande
Soledad Sienra
Jackeline Checa
María Moreno
Jose A. Chabalgoity
Samuel P. Cibulski
Mariana Baz

Frontiers in Immunology

doi 10.3389/fimmu.2023.1163858

4,818 views
5 citations

Brief Research Report

Published on 28 Apr 2023

Host immune responses in aged rhesus macaques against BBV152, an inactivated SARS-CoV-2 vaccine, and cross-neutralization with beta and delta variants

in Vaccines and Molecular Therapeutics

Dilip R. Patil
Anita M. Shete
Pragya D. Yadav
Gajanan N. Sapkal
Gururaj R. Deshpande
Himanshu Kaushal
Sreelekshmy Mohandas
Siddharam Fulari
Rajlaxmi Jain
Ajay Kumar

Frontiers in Immunology

doi 10.3389/fimmu.2023.1161571

1,936 views

Original Research

Published on 27 Apr 2023

Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections

in Vaccines and Molecular Therapeutics

Natalia Egri
Hugo Calderón
Robert Martinez
Mario Vazquez
Verónica Gómez-Caverzaschi
Mariona Pascal
Olga Araújo
Manel Juan
Europa Azucena González-Navarro
José Hernández-Rodríguez

Frontiers in Immunology

doi 10.3389/fimmu.2023.1146841

3,197 views
12 citations

Original Research

Published on 27 Apr 2023

Parents‘ and healthcare professionals’ perception toward the introduction of a new fully liquid hexavalent vaccine in the Malaysian national immunization program: a cross-sectional study instrument development and its application

in Vaccines and Molecular Therapeutics

Lama Al Bashir
Aniza Ismail
Syed Mohamed Aljunid

Frontiers in Immunology

doi 10.3389/fimmu.2023.1052450

2,292 views

Original Research

Published on 27 Apr 2023

A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against Bordetella pertussis

in Vaccines and Molecular Therapeutics

Jingjing Gao
Linlin Huang
Shuquan Luo
Ruijie Qiao
Fanglei Liu
Xin Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1124695

2,642 views
3 citations

Hypothesis and Theory

Published on 26 Apr 2023

Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors

in Vaccines and Molecular Therapeutics

Piotr Rzymski

Frontiers in Immunology

doi 10.3389/fimmu.2023.1183258

3,956 views
10 citations

Original Research

Published on 26 Apr 2023

Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer

in Vaccines and Molecular Therapeutics

Anna Morena D’Alise
Linda Nocchi
Irene Garzia
Laura Seclì
Luigia Infante
Fulvia Troise
Gabriella Cotugno
Simona Allocca
Giuseppina Romano
Armin Lahm

Frontiers in Immunology

doi 10.3389/fimmu.2023.1156714

2,538 views
3 citations

Study Protocol

Published on 26 Apr 2023

Study protocol: a prospective single-center study for non-invasive biomonitoring of renal complications in cancer patients treated with immune checkpoint inhibitors

in Vaccines and Molecular Therapeutics

Eva Baier
Peter Korsten
Arne Strauß
Kai-Martin Thoms
Tobias Overbeck
Philipp Ströbel
Björn Tampe

Frontiers in Immunology

doi 10.3389/fimmu.2023.1140677

1,120 views

Review

Published on 24 Apr 2023

mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV

in Vaccines and Molecular Therapeutics

Laura Matarazzo
Paulo J. G. Bettencourt

Frontiers in Immunology

doi 10.3389/fimmu.2023.1172691

11,929 views
24 citations

Review

Published on 21 Apr 2023

Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics

in Vaccines and Molecular Therapeutics

Vivek P. Chavda
Nidhi Raval
Soham Sheta
Lalitkumar K. Vora
Fatma Elrashdy
Elrashdy M. Redwan
Vladimir N. Uversky
Yavuz Nuri Ertas

Frontiers in Immunology

doi 10.3389/fimmu.2023.1064459

3,414 views
3 citations

Original Research

Published on 21 Apr 2023

Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques

in Vaccines and Molecular Therapeutics

Mohammad Arif Rahman
Manuel Becerra-Flores
Yury Patskovsky
Isabela Silva de Castro
Massimiliano Bissa
Shraddha Basu
Xiaoying Shen
LaTonya D. Williams
Sarkis Sarkis
Kombo F. N’guessan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1139402

3,901 views
2 citations

Original Research

Published on 21 Apr 2023

A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection

in Vaccines and Molecular Therapeutics

Mareike Kubinski
Jana Beicht
Isabel Zdora
Jeannine Biermann
Christina Puff
Thomas Gerlach
Alina Tscherne
Wolfgang Baumgärtner
Albert D. M. E. Osterhaus
Gerd Sutter

Frontiers in Immunology

doi 10.3389/fimmu.2023.1182963

3,408 views
7 citations

Navigation group

Articles

Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals

A linear B-cell epitope close to the furin cleavage site within the S1 domain of SARS-CoV-2 Spike protein discriminates the humoral immune response of nucleic acid- and protein-based vaccine cohorts

Tubeimuside I improves the efficacy of a therapeutic Fusobacterium nucleatum dendritic cell-based vaccine against colorectal cancer

A self-binding immune complex vaccine elicits strong neutralizing responses against herpes simplex virus in mice

Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice

Host immune responses in aged rhesus macaques against BBV152, an inactivated SARS-CoV-2 vaccine, and cross-neutralization with beta and delta variants

Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfections

Parents‘ and healthcare professionals’ perception toward the introduction of a new fully liquid hexavalent vaccine in the Malaysian national immunization program: a cross-sectional study instrument development and its application

A novel vaccine formulation candidate based on lipooligosaccharides and pertussis toxin against Bordetella pertussis

Guillain-Barré syndrome and COVID-19 vaccines: focus on adenoviral vectors

Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer

Study protocol: a prospective single-center study for non-invasive biomonitoring of renal complications in cancer patients treated with immune checkpoint inhibitors

mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV

Blood filtering system for COVID-19 management: novel modality of the cytokine storm therapeutics

Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques

A recombinant Modified Vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection